Candida antigen (Nielsen BioSciences)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCandida antigen (Nielsen BioSciences)
Drug Alias Name念珠菌抗原Candida albicans antigenCandida albicans skin test antigenCandin
ClassificationBiologicsNatural product/Extract > Microbial extract
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHypersensitivitySquamous Cell Carcinoma of Head and NeckWarts +[4] 
Global Approved IndicationsHypersensitivity
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1995/11/27
Country/TerritoryBelgiumUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesNielsen Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesNielsen Biosciences IncJanssen Research & Development LlcUniversity of Arkansas +[4] 
Inactive CompaniesN/A
Active IndicationsHypersensitivitySquamous Cell Carcinoma of Head and NeckWarts
Inactive IndicationsPapillomavirus Infections

Other Information

ATC CodeL03AX
Related LinksN/A